CHINA PHARMA HOLDINGS, INC. Interest Expense Nonoperating
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Interest Expense Nonoperating of $26.36 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $26.36K, a 3.66% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $26.03K, a 7.13% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense nonoperating for the quarter ending 2025-06-30 was $27.36K, a 43.17% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense nonoperating for the quarter ending 2025-03-31 was $28.03K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month |
|---|---|---|---|
| 2026-06-30 | $26.36K 10-Q · filed 2026-08-14 | $52.39K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $26.03K 10-Q · filed 2026-05-15 | ||
| 2025-06-30 | $27.36K 10-Q · filed 2026-08-14 | $55.39K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $28.03K 10-Q · filed 2026-05-15 | ||
| 2024-09-30 | $34.11K 10-Q · filed 2024-11-13 | $82.25K derived: sum of 2 quarters · filed 2024-11-13 | $124.41K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $48.14K 10-Q · filed 2024-08-14 | $90.30K 10-Q · filed 2024-08-14 | |
| 2023-09-30 | $66.24K 10-Q · filed 2024-11-13 | $203.90K derived: sum of 2 quarters · filed 2024-11-13 | $283.35K 10-Q · filed 2024-11-13 |
| 2023-06-30 | $137.66K 10-Q · filed 2024-08-14 | $217.11K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |